Literature DB >> 394636

Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation.

T L Low, G B Thurman, C Chincarini, J E McClure, G D Marshall, S K Hu, A L Goldstein.   

Abstract

Thymosin fraction 5 contains several distinct hormonal-like factors which are effective in partially or fully inducing and maintaining immune function. Several of the peptide components of fraction 5 have been purified, sequenced and studied in assay systems designed to measure T-cell differentiation and function. These studied indicate that a number of the purified peptides act on different subpopulations of T-cells (see Figure 1). Thymosin beta 3 and beta 4 peptides act on terminal deoxynucleotidyl transferase (TdT) negative precursor T-cells to induce TdT positive cells. Thymosin alpha 1 induces the formation of functional helper cells and conversion of Lyt- cells to Lyt 1+, 2+, 3+ cells. Thymosin alpha 7 induces the formation of functional suppressor T-cells and also converts Lyt- cells to Lyt 1+, 2+, 3+ cells. These studies have provided further evidence that the thymus secretes a family of distinct peptides which act at various sites of the maturation sequence of T-cells to induce and maintain immune function. Phase I and Phase II clinical studied with thymosin in the treatment of primary immunodeficiency diseases, autoimmune diseases, and cancer point to a major role of the endocrine thymus in the maintenance of immune balance and in the treatment of diseases characterized by thymic malfunction. It is becoming increasingly clear that immunological maturation is a process involving a complex number of steps and that a single factor initiating a single cellular event might not be reflected in any meaningful immune reconstitution unless it is the only peptide lacking. Given the complexity of the maturation sequence of T-cells and the increasing numbers of T-cell subpopulations that are being identified, it would be surprising if a single thymic factor could control all of the steps and populations involved. Rather, it would appear that the control of T-cell maturation and function involves a complex number of thymic-specific factors and other molecules that rigidly control the intermediary steps in the differentiation process.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 394636     DOI: 10.1111/j.1749-6632.1979.tb47095.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

1.  Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS.

Authors:  C W Tuthill; A Rudolph; Y Li; B Tan; T J Fitzgerald; S R Beck; Y X Li
Journal:  AAPS PharmSciTech       Date:  2000-05-14       Impact factor: 3.246

2.  Primary structure of rat thymus prothymosin alpha.

Authors:  A A Haritos; R Blacher; S Stein; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Immunohistochemical location of prothymosin alpha in regenerating human hepatocytes and hepatocellular carcinomas.

Authors:  M Fraga; T García-Caballero; F Domínguez; E Pérez-Becerra; A Beiras; J Forteza
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Immunomodulation and therapeutic characterization of thymosin fraction five.

Authors:  J E Talmadge; K A Uithoven; B F Lenz; M Chirigos
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine.

Authors:  W B Ershler; A L Moore; M A Socinski
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

6.  Generation of a monoclonal antibody against facteur thymique serique (FTS).

Authors:  K Ohga; G S Incefy; C Y Wang; R A Good
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

7.  Prothymosin alpha in human blood.

Authors:  C Panneerselvam; A A Haritos; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes.

Authors:  I L Sargent; M R Salaman; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

9.  Effect of selected immunoregulatory agents on low-grade contact sensitivity.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

10.  Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V.

Authors:  T M Petro; G Chien; R R Watson
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.